Cardiovascular 3 Flashcards

1
Q

What is an arrhythmia? do we need to intervene?

A

An abnormal heart rate and/or rhythm that results from…..
- Disturbances in impulse formation or in impulse conduction, or both
- Arrhythmias may/may not require intervention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Consider treating arrhythmias when…..

A

Patient is symptomatic
- Causes hemodynamic compromise
- When it may degenerate into a more unstable condition that is life threatening
- Tachyarrhythmia—sustained
- Bradyarrhythmia—sustained
<><><><>
Bradyarrhythmias may require treatment
- Often long term treatment requires pacemaker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the classes of antiarrhythmics used to treat tachyarrhythmias

A
  • Class I (Na+ channel blockers)
  • Class II (β-blockers)
  • Class III (K+ channel blockers)
  • Class IV (Ca2+ channel blockers)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Sodium Channel Blockers
- mechanism, what they do?
- uses

A

This class blocks fast sodium channels that are important during phase zero of depolarization
- Slows conduction velocity in the myocardium
- Known as “membrane stabilizers”
- These agents prolong the refractory period
<><><><>
These agents are used most commonly to treat ventricular tachyarrhythmias (VA’s)
- Ventricular premature contractions (VPCs)
- Ventricular tachycardia (VT)
<><><><>
Occasionally may also be used to treat some supraventricular arrhythmias (SVA’s)
- Paroxysmal supraventricular tachycardia (PSVT)
- Atrial fibrillation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Sodium Channel Blockers that we use

A
  • Class 1A: Quinidine, Procainamide
  • Class 1B: Lidocaine, Mexiletine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Quinidine, Procinamide
- use?

A
  • Limited use in small animals due to adverse effects— proarrhythmic
  • Are both available for oral and injection
  • CV monitoring needed for both drugs
  • Quinidine may still be used in atrial fibrillation in the horse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Class 1B sodium channel blockers vs class 1A

A

Class 1B has more profound effects in abnormal cardiac tissue than Class 1A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Lidocaine, Mexiletine
- uses

A
  • Lidocaine licensed in vet medicine as local anesthetic, not antiarrhythmic
    <><>
  • Lidocaine has value in treatment of VA’s; no value with SVA’s
  • Drug is often given as a loading dose followed by a CRI; extensive first pass metabolism if given orally
  • Lidocaine most effective if serum K+ levels are high normal
    <><><><>
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Lidocaine, Mexiletin toxicity

A
  • Ataxia, drowsiness, seizures (treat with diazepam)
  • Cats sensitive to adverse effects; use not recommended
  • Do not use lidocaine-epinephrine formulations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

β-Blockers as antiarrythmics
- how they work?
- uses
- cautions

A

Exert their antiarrhythmic effects thru inhibition of sympathetics
- Reduces AV nodal conductivity and increased myocyte refractoriness
- Reduces SA firing (depolarizing) rate
<><><><>
In veterinary medicine β-blockers are used……
- Primarily for mgmt. of supraventricular tachyarrhythmias
- May be helpful with ventricular tachyarrhythmias (VTA)
<><><><>
- Careful with decreased contractility in HF eg. DCM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

commonly used beta blockers and their individual properties

A

Atenolol, Esmolol
- Esmolol is an injectable selective β1-blockers with a very short half-life; Used for acute antiarrhythmic therapy
- Atenolol is an oral selective β1-blockers used for chronic tx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Potassium channel blockers
- what they do?

A

As a group these agents prolong the action potential duration and the refractory period
- Act primarily by blockade of K+ channels
- They reduce automaticity of myocardial cells
- May be safer than class I agents for preventing
sudden death in ventricular arrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Sotalol
- what is this drug?
- properties and use?

A
  • Non-selective β-blocker that also blocks myocardial K+ channels
    > β-blocking properties are less than propranolol
    > Also slows AV nodal conduction and will also slow heart rate
    > Maybe of value in treating ventricular tachyarrhythmias in dogs
    > Negative inotropic and proarrhythmic effects are possible
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Amiodarone
- what is this drug? what is its use?
- mechanism?
- adverse effects?

A

Potassium channel blocker
<><>
Amiodarone is reserved for refractory arrhthymias not responding to sotalol or mexiletine
- Produces an increase in refractory period
- Can also block sodium channels, calcium channels and possibly adrenergic receptors
- Amiodarone can also suppress supraventricular tachyarrythmias, such as atrial fibrillation
- Usually used orally, but is available as an injectable
- Potential for serious adverse effects
> Hepatotoxicity, neutropenia, and thrombocytopenia possible
> Holter monitoring recommended

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Potassium channel blockers commonly used

A
  • sotalol
  • Amiodarone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Calcium channel blockers
- which are commonly used?

A
  • diltiazem
17
Q

Calcium channel blockers mechanism

A
  • Effects due to blockade of cardiac calcium channels
  • Slow calcium channel activity is important for depolarization in the SA and AV nodes
    > Slowing of SA depolarization & AV conduction
    > Prolongs AV node refractory period
  • Results in ventricular response to supra-ventricular tachyarrhythmias
    > Atrial fibrillation
    > Paroxysmal supraventricular tachycardia
18
Q

Diltiazem
- properties

A
  • Calcium channel blocker
    > Has minimal effects on VSM calcium channels
    > Available as injectable and oral tablet including extended release forms
19
Q

Digoxin
- use?

A
  • Primary indication in veterinary medicine is for therapy of supraventricular tacharrhythmias including atrial fibrillation
    > May be used in combination with other agents (CCB’s, β-blockers)
    > Moderately effective treatment of supraventricular tachyarrhythmias
    <><><><>
  • increase parasympathetic nerve activity at the SA node, atria and AV node > decrease heart rate
    > Slows the ventricular response
    > Improved baroreceptor function yielding:
    => increased vagal tone
    => decreased sympathetic tone (neuromodulatory)
20
Q

when may we need to treat bradyarrythmias? when can drugs benefit?

A

Treatment of bradyarrhythmias may be necessary when CO is substantially reduced
<><>
Drugs may be of benefit in some cases of bradycardia
- Sinus bradycardia
- Sick sinus syndrome
- Heart block (2nd, 3rd deg)

21
Q

what drugs can be used in the treatment of bradyarrhythmias?

A
  • Anticholinergics (muscarinic blockers): atropine, propantheline
  • Sympathomimetics: isoproterenol
22
Q

Anticholinergics (muscarinic blockers): atropine, propantheline
- when to use for bradyarrhythmia

A
  • Conditions with high vagal tone; block muscarinic receptors
  • Injectable atropine available; oral tablets for both drugs
  • Chronic oral therapy (tablets) may be possible with propantheline
23
Q

Sympathomimetics for bradyarrhythmias
- what do they do?
- which do we use and what are possible adverse effects?

A
  • Sympathomimetics; increase conduction via cardiac β1 receptor
    > Isoproterenol (β1, β2 agonist); given by CRI
    => Can cause hypotension and arrhythmias; ECG monitoring needed